is wegovy a glp-1 medicine weight-loss drugs: PA, NJ poison control centers see more calls With FDA approval of Wegovy

Emerging paramyxoviruses: receptor tropism and zoonotic potential

Modulating energy metabolism presents a new strategy for treating both neurodegenerative diseases and cancer

NOX enzymes produce superoxide anion and other free radicals

Novo Nordisk reacts to Mark Cuban TheStreet explained Cuban's comments to a spokesperson for Novo Nordisk, who offered the following response:

Compared with placebo, the mean pain score improved significantly more with high-dose ALC

The longer the gap in treatment, the bigger the jump in risk up to a 22% increase for heart attack, stroke and death after two years off GLP-1s, largely erasing the cardiovascular benefits gained during treatment